<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Immunotherapy - Wikipedia</title>
<script>document.documentElement.className = document.documentElement.className.replace( /(^|\s)client-nojs(\s|$)/, "$1client-js$2" );</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Immunotherapy","wgTitle":"Immunotherapy","wgCurRevisionId":875634703,"wgRevisionId":875634703,"wgArticleId":226533,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 German-language sources (de)","CS1 French-language sources (fr)","Articles needing additional medical references from April 2018","All articles needing additional references","Articles requiring reliable medical sources","Articles lacking reliable references from April 2018","All articles lacking reliable references","All articles with unsourced statements","Articles with unsourced statements from March 2013","Articles with unsourced statements from April 2016","Wikipedia articles with NDL identifiers","Immunotherapy","Cancer treatments","Virotherapy"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Immunotherapy","wgRelevantArticleId":226533,"wgRequestId":"XD9ybQpAIC4AAAcvk1gAAACX","wgCSPNonce":false,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgWikiEditorEnabledModules":[],"wgBetaFeaturesFeatures":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsShouldSendModuleToUser":true,"wgPopupsConflictsWithNavPopupGadget":false,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en","usePageImages":true,"usePageDescriptions":true},"wgMFExpandAllSectionsUserOption":true,"wgMFEnableFontChanger":true,"wgMFDisplayWikibaseDescriptions":{"search":true,"nearby":true,"watchlist":true,"tagline":false},"wgRelatedArticles":null,"wgRelatedArticlesUseCirrusSearch":true,"wgRelatedArticlesOnlyUseCirrusSearch":false,"wgWMESchemaEditAttemptStepOversample":false,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCentralNoticeCookiesToDelete":[],"wgCentralNoticeCategoriesUsingLegacy":["Fundraising","fundraising"],"wgWikibaseItemId":"Q1427096","wgScoreNoteLanguages":{"arabic":"العربية","catalan":"català","deutsch":"Deutsch","english":"English","espanol":"español","italiano":"italiano","nederlands":"Nederlands","norsk":"norsk","portugues":"português","suomi":"suomi","svenska":"svenska","vlaams":"West-Vlams"},"wgScoreDefaultNoteLanguage":"nederlands","wgCentralAuthMobileDomain":false,"wgCodeMirrorEnabled":true,"wgVisualEditorToolbarScrollOffset":0,"wgVisualEditorUnsupportedEditParams":["undo","undoafter","veswitched"],"wgEditSubmitButtonLabelPublish":true});mw.loader.state({"ext.gadget.charinsert-styles":"ready","ext.globalCssJs.user.styles":"ready","ext.globalCssJs.site.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","ext.globalCssJs.site":"ready","user":"ready","user.options":"ready","user.tokens":"loading","ext.cite.styles":"ready","mediawiki.legacy.shared":"ready","mediawiki.legacy.commonPrint":"ready","mediawiki.toc.styles":"ready","wikibase.client.init":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","ext.3d.styles":"ready","mediawiki.skinning.interface":"ready","skins.vector.styles":"ready"});mw.loader.implement("user.tokens@0tffind",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.startup","mediawiki.page.ready","jquery.tablesorter","mediawiki.toc","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.watchlist-notice","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.eventlogger","ext.uls.init","ext.uls.compactlinks","ext.uls.interface","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","skins.vector.js"];mw.loader.load(RLPAGEMODULES);});</script>
<link rel="stylesheet" href="/w/load.php?debug=false&amp;lang=en&amp;modules=ext.3d.styles%7Cext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.skinning.interface%7Cmediawiki.toc.styles%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector"/>
<script async="" src="/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector"></script>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.charinsert-styles&amp;only=styles&amp;skin=vector"/>
<link rel="stylesheet" href="/w/load.php?debug=false&amp;lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector"/>
<meta name="generator" content="MediaWiki 1.33.0-wmf.12"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Immunotherapy"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Immunotherapy&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Immunotherapy&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Immunotherapy"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/load.php?debug=false&amp;lang=en&amp;modules=html5shiv&amp;only=scripts&amp;skin=vector&amp;sync=1"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Immunotherapy rootpage-Immunotherapy skin-vector action-view">		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>
			<div id="siteNotice" class="mw-body-content"><!-- CentralNotice --></div><div class="mw-indicators mw-body-content">
</div>
<h1 id="firstHeading" class="firstHeading" lang="en">Immunotherapy</h1>			<div id="bodyContent" class="mw-body-content">
				<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>				<div id="contentSub"></div>
				<div id="jump-to-nav"></div>				<a class="mw-jump-link" href="#mw-head">Jump to navigation</a>
				<a class="mw-jump-link" href="#p-search">Jump to search</a>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div role="note" class="hatnote navigation-not-searchable">For the academic journal, see <a href="/wiki/Immunotherapy_(journal)" title="Immunotherapy (journal)">Immunotherapy (journal)</a>.</div>
<table class="box-Medical_citations_needed plainlinks metadata ambox ambox-content" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png" decoding="async" width="40" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x" data-file-width="40" data-file-height="40" /></div></td><td class="mbox-text"><div class="mbox-text-span">This article <b>needs more <a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)">medical references</a> for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a> or relies too heavily on <a href="/wiki/Wikipedia:Primary_sources" class="mw-redirect" title="Wikipedia:Primary sources">primary sources</a></b>.<span class="hide-when-compact"> Please review the contents of the article and <a class="external text" href="//en.wikipedia.org/w/index.php?title=Immunotherapy&amp;action=edit">add the appropriate references</a> if you can. Unsourced or poorly sourced material may be challenged and <a href="/wiki/Wikipedia:Verifiability#Burden_of_evidence" title="Wikipedia:Verifiability">removed</a>.</span>  <small class="date-container"><i>(<span class="date">April 2018</span>)</i></small></div></td><td class="mbox-imageright"><div style="width:52px"><a href="/wiki/File:Rod_of_Asclepius2.svg" class="image"><img alt="Rod of Asclepius2.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Rod_of_Asclepius2.svg/12px-Rod_of_Asclepius2.svg.png" decoding="async" width="12" height="40" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Rod_of_Asclepius2.svg/18px-Rod_of_Asclepius2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Rod_of_Asclepius2.svg/25px-Rod_of_Asclepius2.svg.png 2x" data-file-width="251" data-file-height="804" /></a></div></td></tr></tbody></table>
<table class="box-Primary_sources plainlinks metadata ambox ambox-content ambox-Primary_sources" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="Question book-new.svg" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" decoding="async" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="512" data-file-height="399" /></a></div></td><td class="mbox-text"><div class="mbox-text-span">This article <b>relies too much on <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">references</a> to <a href="/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources" title="Wikipedia:No original research">primary sources</a></b>.<span class="hide-when-compact"> Please improve this  by adding <a href="/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources" title="Wikipedia:No original research">secondary or tertiary sources</a>.</span>  <small class="date-container"><i>(<span class="date">April 2018</span>)</i></small><small class="hide-when-compact"><i> (<a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>
<table class="infobox" style="width:22em"><tbody><tr><th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightblue">Immunotherapy</th></tr><tr><th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th><td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&amp;term=D007167">D007167</a></span></td></tr><tr><th scope="row"><a href="/wiki/OPS-301" title="OPS-301">OPS-301&#160;code</a></th><td><a rel="nofollow" class="external text" href="http://ops.icd-code.de/ops/code/8-03.html">8-03</a></td></tr><tr class="noprint"><td colspan="2" style="text-align:center"><div style="text-align: right;">&#91;<a href="https://www.wikidata.org/wiki/Q1427096" class="extiw" title="d:Q1427096">edit on Wikidata</a>]</div></td></tr></tbody></table>
<p><b>Immunotherapy</b> is the treatment of <a href="/wiki/Disease" title="Disease">disease</a> by activating or suppressing the <a href="/wiki/Immune_system" title="Immune system">immune system</a>. Immunotherapies designed to elicit or amplify an immune response are classified as <b>activation immunotherapies,</b> while immunotherapies that reduce or suppress are classified as <b><a href="/wiki/Immunosuppression" title="Immunosuppression">suppression immunotherapies</a>.</b>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:CAR_T-cell_Therapy.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/CAR_T-cell_Therapy.svg/220px-CAR_T-cell_Therapy.svg.png" decoding="async" width="220" height="69" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/CAR_T-cell_Therapy.svg/330px-CAR_T-cell_Therapy.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b6/CAR_T-cell_Therapy.svg/440px-CAR_T-cell_Therapy.svg.png 2x" data-file-width="512" data-file-height="160" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:CAR_T-cell_Therapy.svg" class="internal" title="Enlarge"></a></div>The diagram above represents the process of chimeric antigen receptor T-cell therapy (CAR), this is a method of immunotherapy, which is a growing practice in the treatment of cancer. The final result should be a  production of equipped T-cells that can recognize and fight the infected cancer cells in the body. <div><ol><li>T-cells (represented by objects labeled as ’t’) are removed from the patient's blood.</li><li>Then in a lab setting the gene that encodes for the specific antigen receptors are incorporated into the T-cells.</li><li>Thus producing the CAR receptors (labeled as c) on the surface of the cells.</li><li>The newly modified T-cells are then further harvested and grown in the lab.</li><li>After a certain time period, the engineered T-cells are infused back into the patient.</li></ol></div></div></div></div>
<p>In recent years, immunotherapy has become of great interest to researchers, clinicians and <a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">pharmaceutical companies</a>, particularly in its promise to treat various forms of <a href="/wiki/Cancer" title="Cancer">cancer</a>.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1">&#91;1&#93;</a></sup><sup id="cite_ref-:0_2-0" class="reference"><a href="#cite_note-:0-2">&#91;2&#93;</a></sup>
</p><p>Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating <a href="/wiki/Antimicrobial_resistance" title="Antimicrobial resistance">resistance</a> when treating microbial disease.<sup id="cite_ref-pmid11727500_3-0" class="reference"><a href="#cite_note-pmid11727500-3">&#91;3&#93;</a></sup>
</p><p>Cell-based immunotherapies are effective for some cancers. Immune effector cells such as <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a>, <a href="/wiki/Macrophage" title="Macrophage">macrophages</a>, <a href="/wiki/Dendritic_cell" title="Dendritic cell">dendritic cells</a>, <a href="/wiki/Natural_killer_cell" title="Natural killer cell">natural killer cells</a> (NK Cell), <a href="/wiki/Cytotoxic_T_cell" title="Cytotoxic T cell">cytotoxic T lymphocytes</a> (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
</p><p>Therapies such as <a href="/wiki/Granulocyte_colony-stimulating_factor" title="Granulocyte colony-stimulating factor">granulocyte colony-stimulating factor</a> (G-CSF), <a href="/wiki/Interferon" title="Interferon">interferons</a>, <a href="/wiki/Imiquimod" title="Imiquimod">imiquimod</a> and cellular membrane fractions from <a href="/wiki/Bacteria" title="Bacteria">bacteria</a> are licensed for medical use. Others including <a href="/wiki/Interleukin-2" class="mw-redirect" title="Interleukin-2">IL-2</a>, <a href="/wiki/Interleukin-7" class="mw-redirect" title="Interleukin-7">IL-7</a>, <a href="/wiki/Interleukin_12" title="Interleukin 12">IL-12</a>, various <a href="/wiki/Chemokine" title="Chemokine">chemokines</a>, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and <a href="/wiki/Glucan" title="Glucan">glucans</a> are involved in clinical and preclinical studies.
</p>
<style data-mw-deduplicate="TemplateStyles:r872693506">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><div id="toc" class="toc"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2>Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Immunomodulators"><span class="tocnumber">1</span> <span class="toctext">Immunomodulators</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Activation_immunotherapies"><span class="tocnumber">2</span> <span class="toctext">Activation immunotherapies</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Cancer"><span class="tocnumber">2.1</span> <span class="toctext">Cancer</span></a>
<ul>
<li class="toclevel-3 tocsection-4"><a href="#Dendritic_cell-based_pump-priming"><span class="tocnumber">2.1.1</span> <span class="toctext">Dendritic cell-based pump-priming</span></a></li>
<li class="toclevel-3 tocsection-5"><a href="#T-cell_adoptive_transfer"><span class="tocnumber">2.1.2</span> <span class="toctext">T-cell adoptive transfer</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-6"><a href="#Immune_enhancement_therapy"><span class="tocnumber">3</span> <span class="toctext">Immune enhancement therapy</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Suppression_immunotherapies"><span class="tocnumber">4</span> <span class="toctext">Suppression immunotherapies</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Immunosuppressive_drugs"><span class="tocnumber">4.1</span> <span class="toctext">Immunosuppressive drugs</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Immune_tolerance"><span class="tocnumber">4.2</span> <span class="toctext">Immune tolerance</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Allergies"><span class="tocnumber">4.3</span> <span class="toctext">Allergies</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-11"><a href="#Helminthic_therapies"><span class="tocnumber">5</span> <span class="toctext">Helminthic therapies</span></a></li>
<li class="toclevel-1 tocsection-12"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Immunomodulators">Immunomodulators</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=1" title="Edit section: Immunomodulators">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Immunomodulators are the active agents of immunotherapy. They are a diverse array of recombinant, synthetic, and natural preparations.  
</p>
<table class="wikitable sortable" style="text-align:center">
<tbody><tr>
<th>Class</th>
<th>Example agents
</th></tr>
<tr>
<td><a href="/wiki/Interleukins" class="mw-redirect" title="Interleukins">Interleukins</a></td>
<td><a href="/wiki/Interleukin_2" title="Interleukin 2">IL-2</a>, <a href="/wiki/Interleukin_7" title="Interleukin 7">IL-7</a>, <a href="/wiki/Interleukin_12" title="Interleukin 12">IL-12</a>
</td></tr>
<tr>
<td><a href="/wiki/Cytokines" class="mw-redirect" title="Cytokines">Cytokines</a></td>
<td><a href="/wiki/Interferon" title="Interferon">Interferons</a>, <a href="/wiki/G-CSF" class="mw-redirect" title="G-CSF">G-CSF</a>
</td></tr>
<tr>
<td><a href="/wiki/Chemokines" class="mw-redirect" title="Chemokines">Chemokines</a></td>
<td><a href="/wiki/CCL3" title="CCL3">CCL3</a>, <a href="/wiki/CCL26" title="CCL26">CCL26</a>, <a href="/wiki/CXCL7" title="CXCL7">CXCL7</a>
</td></tr>

<tr>
<td><a href="/wiki/Immunomodulatory_imide_drug" title="Immunomodulatory imide drug">Immunomodulatory imide drugs</a> (IMiDs)</td>
<td><a href="/wiki/Thalidomide" title="Thalidomide">thalidomide</a> and its analogues (<a href="/wiki/Lenalidomide" title="Lenalidomide">lenalidomide</a>, <a href="/wiki/Pomalidomide" title="Pomalidomide">pomalidomide</a>, and <a href="/wiki/Apremilast" title="Apremilast">apremilast</a>)
</td></tr>
<tr>
<td>Other</td>
<td>cytosine phosphate-guanosine, oligodeoxynucleotides, <a href="/wiki/Glucans" class="mw-redirect" title="Glucans">glucans</a>
</td></tr>
</tbody></table>
<h2><span class="mw-headline" id="Activation_immunotherapies">Activation immunotherapies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=2" title="Edit section: Activation immunotherapies">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Cancer">Cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=3" title="Edit section: Cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Cancer_immunotherapy" title="Cancer immunotherapy">Cancer immunotherapy</a></div>
<p>Cancer immunotherapy attempts to stimulate the <a href="/wiki/Immune_system" title="Immune system">immune system</a> to destroy tumors. A variety of strategies are in use or are undergoing research and testing. Randomized controlled studies in different cancers resulting in significant increase in survival and disease free period have been reported<sup id="cite_ref-:0_2-1" class="reference"><a href="#cite_note-:0-2">&#91;2&#93;</a></sup>  and its efficacy is enhanced by 20–30% when cell-based immunotherapy is combined with conventional treatment methods.<sup id="cite_ref-:0_2-2" class="reference"><a href="#cite_note-:0-2">&#91;2&#93;</a></sup>
</p><p>One of the oldest forms of cancer immunotherapy is the use of <a href="/wiki/BCG_vaccine" title="BCG vaccine">BCG vaccine</a>, which was originally to vaccinate against <a href="/wiki/Tuberculosis" title="Tuberculosis">tuberculosis</a> and later was found to be useful in the treatment of <a href="/wiki/Bladder_cancer" title="Bladder cancer">bladder cancer</a>.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">&#91;4&#93;</a></sup>
</p><p>The extraction of <a href="/wiki/Granulocyte_colony-stimulating_factor" title="Granulocyte colony-stimulating factor">G-CSF</a> <a href="/wiki/Lymphocytes" class="mw-redirect" title="Lymphocytes">lymphocytes</a> from the blood and expanding in vitro against a tumour antigen before reinjecting the cells with appropriate stimulatory <a href="/wiki/Cytokines" class="mw-redirect" title="Cytokines">cytokines</a>. The cells then destroy the tumor cells that express the <a href="/wiki/Antigen" title="Antigen">antigen</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2013)">citation needed</span></a></i>&#93;</sup>
</p><p>Topical immunotherapy utilizes an immune enhancement cream (<a href="/wiki/Imiquimod" title="Imiquimod">imiquimod</a>) which produces <a href="/wiki/Interferon" title="Interferon">interferon</a>, causing the recipient's killer <a href="/wiki/T_cells" class="mw-redirect" title="T cells">T cells</a> to destroy <a href="/wiki/Wart" title="Wart">warts</a>,<sup id="cite_ref-pmid18385498_5-0" class="reference"><a href="#cite_note-pmid18385498-5">&#91;5&#93;</a></sup> <a href="/wiki/Actinic_keratoses" class="mw-redirect" title="Actinic keratoses">actinic keratoses</a>, <a href="/wiki/Basal_cell_cancer" class="mw-redirect" title="Basal cell cancer">basal cell cancer</a>, <a href="/wiki/Vaginal_intraepithelial_neoplasia" title="Vaginal intraepithelial neoplasia">vaginal intraepithelial neoplasia</a>,<sup id="cite_ref-pmid17051086_6-0" class="reference"><a href="#cite_note-pmid17051086-6">&#91;6&#93;</a></sup> squamous cell cancer,<sup id="cite_ref-pmid19395154_7-0" class="reference"><a href="#cite_note-pmid19395154-7">&#91;7&#93;</a></sup><sup id="cite_ref-pmid19442565_8-0" class="reference"><a href="#cite_note-pmid19442565-8">&#91;8&#93;</a></sup> cutaneous lymphoma,<sup id="cite_ref-pmid19273388_9-0" class="reference"><a href="#cite_note-pmid19273388-9">&#91;9&#93;</a></sup> and superficial malignant melanoma.<sup id="cite_ref-pmid19464602_10-0" class="reference"><a href="#cite_note-pmid19464602-10">&#91;10&#93;</a></sup>
</p><p>Injection immunotherapy ("intralesional" or "intratumoral") uses mumps, candida, the HPV vaccine<sup id="cite_ref-pmid19473507_11-0" class="reference"><a href="#cite_note-pmid19473507-11">&#91;11&#93;</a></sup><sup id="cite_ref-pmid19353471_12-0" class="reference"><a href="#cite_note-pmid19353471-12">&#91;12&#93;</a></sup> or <a href="/w/index.php?title=Trichophytin&amp;action=edit&amp;redlink=1" class="new" title="Trichophytin (page does not exist)">trichophytin</a> <a href="/wiki/Antigen" title="Antigen">antigen</a> injections to treat warts (HPV induced tumors).
</p><p><a href="/wiki/Adoptive_cell_transfer" title="Adoptive cell transfer">Adoptive cell transfer</a> has been tested on <a href="/wiki/Lung_cancer" title="Lung cancer">lung</a> <sup id="cite_ref-pmid19471115_13-0" class="reference"><a href="#cite_note-pmid19471115-13">&#91;13&#93;</a></sup> and other cancers, with greatest success achieved in <a href="/wiki/Melanoma" title="Melanoma">melanoma</a>.
</p>
<h4><span class="mw-headline" id="Dendritic_cell-based_pump-priming">Dendritic cell-based pump-priming</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=4" title="Edit section: Dendritic cell-based pump-priming">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Dendritic_cells" class="mw-redirect" title="Dendritic cells">Dendritic cells</a> can be stimulated to activate a <a href="/wiki/Cytotoxic" class="mw-redirect" title="Cytotoxic">cytotoxic</a> response towards an <a href="/wiki/Antigen" title="Antigen">antigen</a>. Dendritic cells, a type of <a href="/wiki/Antigen_presenting_cell" class="mw-redirect" title="Antigen presenting cell">antigen presenting cell</a>, are harvested from the person needing the immunotherapy. These cells are then either pulsed with an antigen or tumor lysate or <a href="/wiki/Transfection" title="Transfection">transfected</a> with a <a href="/wiki/Viral_vector" title="Viral vector">viral vector</a>, causing them to display the antigen. Upon transfusion into the person, these activated cells present the antigen to the effector lymphocytes (<a href="/wiki/Cytotoxic_T_cell" title="Cytotoxic T cell">CD4+ helper T cells</a>, cytotoxic <a href="/wiki/Cytotoxic_T_cell" title="Cytotoxic T cell">CD8+ T cells</a> and <a href="/wiki/B_cell" title="B cell">B cells</a>). This initiates a cytotoxic response against tumor cells expressing the antigen (against which the adaptive response has now been primed). The <a href="/wiki/Cancer_vaccine" title="Cancer vaccine">cancer vaccine</a> <a href="/wiki/Sipuleucel-T" title="Sipuleucel-T">Sipuleucel-T</a> is one example of this approach.<sup id="cite_ref-pmid21606971_14-0" class="reference"><a href="#cite_note-pmid21606971-14">&#91;14&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="T-cell_adoptive_transfer">T-cell adoptive transfer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=5" title="Edit section: T-cell adoptive transfer">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Adoptive_cell_transfer" title="Adoptive cell transfer">Adoptive cell transfer</a> <i><a href="/wiki/In_vitro" title="In vitro">in vitro</a></i> cultivates autologous, extracted T cells for later transfusion.<sup id="cite_ref-Rosenberg_15-0" class="reference"><a href="#cite_note-Rosenberg-15">&#91;15&#93;</a></sup>
</p><p>Alternatively, <a href="/wiki/Genetically_engineered_T_cell" class="mw-redirect" title="Genetically engineered T cell">Genetically engineered T cells</a> are created by harvesting T cells and then infecting the T cells with a <a href="/wiki/Retrovirus" title="Retrovirus">retrovirus</a> that contains a copy of a <a href="/wiki/T_cell_receptor" class="mw-redirect" title="T cell receptor">T cell receptor</a> (TCR) gene that is specialised to recognise tumour antigens. The virus integrates the receptor into the T cells' <a href="/wiki/Genome" title="Genome">genome</a>. The cells are expanded non-specifically and/or stimulated. The cells are then reinfused and produce an immune response against the tumour cells.<sup id="cite_ref-Morgan_16-0" class="reference"><a href="#cite_note-Morgan-16">&#91;16&#93;</a></sup> The technique has been tested on refractory stage IV metastatic melanomas<sup id="cite_ref-Rosenberg_15-1" class="reference"><a href="#cite_note-Rosenberg-15">&#91;15&#93;</a></sup> and advanced <a href="/wiki/Skin_cancer" title="Skin cancer">skin cancer</a><sup id="cite_ref-Hunder_17-0" class="reference"><a href="#cite_note-Hunder-17">&#91;17&#93;</a></sup><sup id="cite_ref-urlCancer_Research_Institute_-_2008_Symposium_Program_&amp;_Speakers_18-0" class="reference"><a href="#cite_note-urlCancer_Research_Institute_-_2008_Symposium_Program_&amp;_Speakers-18">&#91;18&#93;</a></sup><sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup>
</p><p>Whether T cells are genetically engineered or not, before reinfusion, lymphodepletion of the recipient is required to eliminate regulatory T cells as well as unmodified, endogenous lymphocytes that compete with the transferred cells for homeostatic cytokines.<sup id="cite_ref-Rosenberg_15-2" class="reference"><a href="#cite_note-Rosenberg-15">&#91;15&#93;</a></sup><sup id="cite_ref-Antony_20-0" class="reference"><a href="#cite_note-Antony-20">&#91;20&#93;</a></sup><sup id="cite_ref-Gattinoni_21-0" class="reference"><a href="#cite_note-Gattinoni-21">&#91;21&#93;</a></sup><sup id="cite_ref-Dummer_22-0" class="reference"><a href="#cite_note-Dummer-22">&#91;22&#93;</a></sup> Lymphodepletion may be achieved by <a href="/wiki/Hematopoietic_stem_cell_transplantation#Myeloablative" title="Hematopoietic stem cell transplantation">myeloablative</a> chemotherapy, to which total body irradiation may be added for greater effect.<sup id="cite_ref-Dudley08_23-0" class="reference"><a href="#cite_note-Dudley08-23">&#91;23&#93;</a></sup> Transferred cells multiplied <i>in vivo</i> and persisted in peripheral blood in many people, sometimes representing levels of 75% of all CD8<sup>+</sup> T cells at 6–12 months after infusion.<sup id="cite_ref-Dudley02_24-0" class="reference"><a href="#cite_note-Dudley02-24">&#91;24&#93;</a></sup> As of 2012, clinical trials for metastatic melanoma were ongoing at multiple sites.<sup id="cite_ref-pmid22996367_25-0" class="reference"><a href="#cite_note-pmid22996367-25">&#91;25&#93;</a></sup> Clinical responses to adoptive transfer of T cells were observed in patients with metastatic melanoma resistant to multiple immunotherapies.<sup id="cite_ref-pmid29688262_26-0" class="reference"><a href="#cite_note-pmid29688262-26">&#91;26&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Immune_enhancement_therapy">Immune enhancement therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=6" title="Edit section: Immune enhancement therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Autologous_immune_enhancement_therapy" title="Autologous immune enhancement therapy">Autologous immune enhancement therapy</a> use a person's own peripheral blood-derived <a href="/wiki/Natural_killer_cell" title="Natural killer cell">natural killer cells</a>, cytotoxic T lymphocytes and other relevant immune cells are expanded <i>in vitro</i> and then reinfused.<sup id="cite_ref-Manjunath_27-0" class="reference"><a href="#cite_note-Manjunath-27">&#91;27&#93;</a></sup> The therapy has been tested against <a href="/wiki/Hepatitis_C" title="Hepatitis C">Hepatitis C</a>,<sup id="cite_ref-Doskali_M_28-0" class="reference"><a href="#cite_note-Doskali_M-28">&#91;28&#93;</a></sup><sup id="cite_ref-Li_Y_29-0" class="reference"><a href="#cite_note-Li_Y-29">&#91;29&#93;</a></sup><sup id="cite_ref-Terunuma_H_30-0" class="reference"><a href="#cite_note-Terunuma_H-30">&#91;30&#93;</a></sup> <a href="/wiki/Chronic_fatigue_syndrome" title="Chronic fatigue syndrome">Chronic fatigue syndrome</a><sup id="cite_ref-See_DM_31-0" class="reference"><a href="#cite_note-See_DM-31">&#91;31&#93;</a></sup><sup id="cite_ref-Ojo-Amaize_EA_32-0" class="reference"><a href="#cite_note-Ojo-Amaize_EA-32">&#91;32&#93;</a></sup> and <a href="/wiki/HHV6" class="mw-redirect" title="HHV6">HHV6</a> infection.<sup id="cite_ref-Kida_K_33-0" class="reference"><a href="#cite_note-Kida_K-33">&#91;33&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Suppression_immunotherapies">Suppression immunotherapies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=7" title="Edit section: Suppression immunotherapies">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Immune_suppression" class="mw-redirect" title="Immune suppression">Immune suppression</a> dampens an abnormal <a href="/wiki/Immune_response" title="Immune response">immune response</a> in <a href="/wiki/Autoimmune_diseases" class="mw-redirect" title="Autoimmune diseases">autoimmune diseases</a> or reduces a normal <a href="/wiki/Immune_response" title="Immune response">immune response</a> to prevent <a href="/wiki/Transplant_rejection" title="Transplant rejection">rejection</a> of <a href="/wiki/Organ_transplant" class="mw-redirect" title="Organ transplant">transplanted</a> organs or cells.
</p>
<h3><span class="mw-headline" id="Immunosuppressive_drugs">Immunosuppressive drugs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=8" title="Edit section: Immunosuppressive drugs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Immunosuppressive_drug" title="Immunosuppressive drug">Immunosuppressive drugs</a> help manage organ transplantation and autoimmune disease. Immune responses depend on lymphocyte proliferation. <a href="/wiki/Immunosuppressive_drug#Cytostatics" title="Immunosuppressive drug">Cytostatic drugs</a> are immunosuppressive. <a href="/wiki/Immunosuppressive_drug#Glucocorticoids" title="Immunosuppressive drug">Glucocorticoids</a> are somewhat more specific inhibitors of lymphocyte activation, whereas inhibitors of <a href="/wiki/Immunosuppressive_drug#Drugs_acting_on_immunophilins" title="Immunosuppressive drug">immunophilins</a> more specifically target T lymphocyte activation. <a href="/wiki/Immunosuppressive_drug#Antibodies" title="Immunosuppressive drug">Immunosuppressive antibodies</a> target steps in the immune response. <a href="/wiki/Immunosuppressive_drug#Other_drugs" title="Immunosuppressive drug">Other drugs</a> modulate immune responses.
</p>
<h3><span class="mw-headline" id="Immune_tolerance">Immune tolerance</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=9" title="Edit section: Immune tolerance">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Immune_tolerance" title="Immune tolerance">Immune tolerance</a></div>
<p>The body naturally does not launch an immune system attack on its own tissues. Immune tolerance therapies seek to reset the immune system so that the body stops mistakenly attacking its own organs or cells in <a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune disease</a> or accepts foreign tissue in <a href="/wiki/Organ_transplant" class="mw-redirect" title="Organ transplant">organ transplantation</a>.<sup id="cite_ref-pmid12110811_34-0" class="reference"><a href="#cite_note-pmid12110811-34">&#91;34&#93;</a></sup> Creating immunity reduces or eliminates the need for lifelong immunosuppression and attendant side effects. It has been tested on transplantations, and <a href="/wiki/Type_1_diabetes" class="mw-redirect" title="Type 1 diabetes">type 1 diabetes</a> or other autoimmune disorders.
</p>
<h3><span class="mw-headline" id="Allergies">Allergies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=10" title="Edit section: Allergies">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Allergen_immunotherapy" title="Allergen immunotherapy">Allergen immunotherapy</a></div>
<p>Immunotherapy is used to treat <a href="/wiki/Allergy" title="Allergy">allergies</a>. While allergy treatments (such as <a href="/wiki/Antihistamine" title="Antihistamine">antihistamines</a> or <a href="/wiki/Corticosteroids" class="mw-redirect" title="Corticosteroids">corticosteroids</a>) treat allergic symptoms, immunotherapy can reduce sensitivity to <a href="/wiki/Allergen" title="Allergen">allergens</a>, lessening its severity.
</p><p>Immunotherapy may produce long-term benefits.<sup id="cite_ref-pmid10441602_35-0" class="reference"><a href="#cite_note-pmid10441602-35">&#91;35&#93;</a></sup> Immunotherapy is partly effective in some people and ineffective in others, but it offers allergy sufferers a chance to reduce or stop their symptoms.
</p><p>The therapy is indicated for people who are extremely allergic or who cannot avoid specific <a href="/wiki/Allergen" title="Allergen">allergens</a>. Immunotherapy is generally not indicated for food or medicinal allergies. This therapy is particularly useful for people with <a href="/wiki/Allergic_rhinitis" title="Allergic rhinitis">allergic rhinitis</a> or <a href="/wiki/Asthma" title="Asthma">asthma</a>.
</p><p>The first dose contain tiny amounts of the allergen or antigen. Dosages increase over time, as the person becomes desensitized. This technique has been tested on infants to prevent peanut allergies.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Helminthic_therapies">Helminthic therapies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=11" title="Edit section: Helminthic therapies">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Whipworm" class="mw-redirect" title="Whipworm">Whipworm</a> <a href="/wiki/Ovum" class="mw-redirect" title="Ovum">ova</a> (<i>Trichuris suis</i>) and <a href="/wiki/Hookworm" title="Hookworm">Hookworm</a> (<i>Necator americanus</i>) have been tested for immunological diseases and allergies. <a href="/wiki/Helminthic_therapy" title="Helminthic therapy">Helminthic therapy</a> has been investigated as a treatment for relapsing remitting <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a><sup id="cite_ref-pmid17230481_37-0" class="reference"><a href="#cite_note-pmid17230481-37">&#91;37&#93;</a></sup> <a href="/wiki/Crohn%27s_disease" title="Crohn&#39;s disease">Crohn’s</a>,<sup id="cite_ref-pmid16344586_38-0" class="reference"><a href="#cite_note-pmid16344586-38">&#91;38&#93;</a></sup><sup id="cite_ref-pmid19050918_39-0" class="reference"><a href="#cite_note-pmid19050918-39">&#91;39&#93;</a></sup><sup id="cite_ref-pmid18619749_40-0" class="reference"><a href="#cite_note-pmid18619749-40">&#91;40&#93;</a></sup> allergies and asthma.<sup id="cite_ref-pmid16965287_41-0" class="reference"><a href="#cite_note-pmid16965287-41">&#91;41&#93;</a></sup> The mechanism of how the helminths modulate the immune response, is unknown. Hypothesized mechanisms include re-polarisation of the Th1 / Th2 response<sup id="cite_ref-pmid15603764_42-0" class="reference"><a href="#cite_note-pmid15603764-42">&#91;42&#93;</a></sup> and modulation of dendritic cell function.<sup id="cite_ref-pmid19308259_43-0" class="reference"><a href="#cite_note-pmid19308259-43">&#91;43&#93;</a></sup><sup id="cite_ref-pmid19120496_44-0" class="reference"><a href="#cite_note-pmid19120496-44">&#91;44&#93;</a></sup> The helminths down regulate the pro-inflammatory Th1 cytokines, <a href="/wiki/Interleukin-12" class="mw-redirect" title="Interleukin-12">Interleukin-12</a> (IL-12), Interferon-Gamma (IFN-γ) and <a href="/wiki/Tumour_Necrosis_Factor" class="mw-redirect" title="Tumour Necrosis Factor">Tumour Necrosis Factor-Alpha</a> (TNF-ά), while promoting the production of regulatory Th2 cytokines such as <a href="/wiki/Interleukin_10" title="Interleukin 10">IL-10</a>, <a href="/wiki/Interleukin-4" class="mw-redirect" title="Interleukin-4">IL-4</a>, <a href="/wiki/Interleukin_5" title="Interleukin 5">IL-5</a> and <a href="/wiki/Interleukin_13" title="Interleukin 13">IL-13</a>.<sup id="cite_ref-pmid15603764_42-1" class="reference"><a href="#cite_note-pmid15603764-42">&#91;42&#93;</a></sup><sup id="cite_ref-pmid19468064_45-0" class="reference"><a href="#cite_note-pmid19468064-45">&#91;45&#93;</a></sup>
</p><p>Co-evolution with helminths has shaped some of the genes associated with <a href="/wiki/Interleukin" title="Interleukin">Interleukin</a> expression and immunological disorders, such <a href="/wiki/Crohn%27s" class="mw-redirect" title="Crohn&#39;s">Crohn's</a>, <a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">ulcerative colitis</a> and <a href="/wiki/Coeliac_disease" title="Coeliac disease">celiac disease</a>. Helminth's relationship to humans as hosts should be classified as mutualistic or <a href="/wiki/Symbionts" class="mw-redirect" title="Symbionts">symbiotic</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2016)">citation needed</span></a></i>&#93;</sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=12" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/Biological_response_modifiers" title="Biological response modifiers">Biological response modifiers</a></li>
<li><a href="/wiki/Checkpoint_inhibitor" title="Checkpoint inhibitor">Checkpoint inhibitor</a></li>
<li><a href="/wiki/Interleukin-2_immunotherapy" class="mw-redirect" title="Interleukin-2 immunotherapy">Interleukin-2 immunotherapy</a></li>
<li><a href="/wiki/Microtransplantation" title="Microtransplantation">Microtransplantation</a></li></ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=13" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/immunotherapy">"Immunotherapy | Memorial Sloan Kettering Cancer Center"</a>. <i>www.mskcc.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2017-07-27</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.mskcc.org&amp;rft.atitle=Immunotherapy+%7C+Memorial+Sloan+Kettering+Cancer+Center&amp;rft_id=https%3A%2F%2Fwww.mskcc.org%2Fcancer-care%2Fdiagnosis-treatment%2Fcancer-treatments%2Fimmunotherapy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r861714446">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"\"""\"""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-:0-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:0_2-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Syn, Nicholas L; Teng, Michele W L; Mok, Tony S K; Soo, Ross A. "De-novo and acquired resistance to immune checkpoint targeting". <i>The Lancet Oncology</i>. <b>18</b> (12): e731–e741. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1016%2Fs1470-2045%2817%2930607-1">10.1016/s1470-2045(17)30607-1</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet+Oncology&amp;rft.atitle=De-novo+and+acquired+resistance+to+immune+checkpoint+targeting&amp;rft.volume=18&amp;rft.issue=12&amp;rft.pages=e731-e741&amp;rft_id=info%3Adoi%2F10.1016%2Fs1470-2045%2817%2930607-1&amp;rft.aulast=Syn&amp;rft.aufirst=Nicholas+L&amp;rft.au=Teng%2C+Michele+W+L&amp;rft.au=Mok%2C+Tony+S+K&amp;rft.au=Soo%2C+Ross+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid11727500-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11727500_3-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Masihi KN (July 2001). "Fighting infection using immunomodulatory agents". <i>Expert Opin Biol Ther</i>. <b>1</b> (4): 641–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1517%2F14712598.1.4.641">10.1517/14712598.1.4.641</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11727500">11727500</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opin+Biol+Ther&amp;rft.atitle=Fighting+infection+using+immunomodulatory+agents&amp;rft.volume=1&amp;rft.issue=4&amp;rft.pages=641-53&amp;rft.date=2001-07&amp;rft_id=info%3Adoi%2F10.1517%2F14712598.1.4.641&amp;rft_id=info%3Apmid%2F11727500&amp;rft.au=Masihi+KN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><cite class="citation journal">Fuge, O; Vasdev, N; Allchorne, P; Green, JS (2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4427258">"Immunotherapy for bladder cancer"</a>. <i>Research and Reports in Urology</i>. <b>7</b>: 65–79. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.2147%2FRRU.S63447">10.2147/RRU.S63447</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4427258">4427258</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/26000263">26000263</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Research+and+Reports+in+Urology&amp;rft.atitle=Immunotherapy+for+bladder+cancer&amp;rft.volume=7&amp;rft.pages=65-79&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4427258&amp;rft_id=info%3Apmid%2F26000263&amp;rft_id=info%3Adoi%2F10.2147%2FRRU.S63447&amp;rft.aulast=Fuge&amp;rft.aufirst=O&amp;rft.au=Vasdev%2C+N&amp;rft.au=Allchorne%2C+P&amp;rft.au=Green%2C+JS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4427258&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid18385498-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18385498_5-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, Kagie MJ, Meijer CJ, Aaronson NK, Kleinjan A, Heijmans-Antonissen C, Zijlstra FJ, Burger MP, Helmerhorst TJ (April 2008). "Treatment of vulvar intraepithelial neoplasia with topical imiquimod". <i>N. Engl. J. Med</i>. <b>358</b> (14): 1465–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1056%2FNEJMoa072685">10.1056/NEJMoa072685</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18385498">18385498</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.atitle=Treatment+of+vulvar+intraepithelial+neoplasia+with+topical+imiquimod&amp;rft.volume=358&amp;rft.issue=14&amp;rft.pages=1465-73&amp;rft.date=2008-04&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa072685&amp;rft_id=info%3Apmid%2F18385498&amp;rft.aulast=van+Seters&amp;rft.aufirst=M&amp;rft.au=van+Beurden%2C+M&amp;rft.au=ten+Kate%2C+FJ&amp;rft.au=Beckmann%2C+I&amp;rft.au=Ewing%2C+PC&amp;rft.au=Eijkemans%2C+MJ&amp;rft.au=Kagie%2C+MJ&amp;rft.au=Meijer%2C+CJ&amp;rft.au=Aaronson%2C+NK&amp;rft.au=Kleinjan%2C+A&amp;rft.au=Heijmans-Antonissen%2C+C&amp;rft.au=Zijlstra%2C+FJ&amp;rft.au=Burger%2C+MP&amp;rft.au=Helmerhorst%2C+TJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid17051086-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17051086_6-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Buck HW, Guth KJ (October 2003). "Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream". <i>J Low Genit Tract Dis</i>. <b>7</b> (4): 290–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1097%2F00128360-200310000-00011">10.1097/00128360-200310000-00011</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17051086">17051086</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Low+Genit+Tract+Dis&amp;rft.atitle=Treatment+of+vaginal+intraepithelial+neoplasia+%28primarily+low+grade%29+with+imiquimod+5%25+cream&amp;rft.volume=7&amp;rft.issue=4&amp;rft.pages=290-3&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1097%2F00128360-200310000-00011&amp;rft_id=info%3Apmid%2F17051086&amp;rft.aulast=Buck&amp;rft.aufirst=HW&amp;rft.au=Guth%2C+KJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19395154-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19395154_7-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Järvinen R, Kaasinen E, Sankila A, Rintala E (August 2009). "Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up". <i>Eur. Urol</i>. <b>56</b> (2): 260–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1016%2Fj.eururo.2009.04.009">10.1016/j.eururo.2009.04.009</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19395154">19395154</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Eur.+Urol.&amp;rft.atitle=Long-term+efficacy+of+maintenance+bacillus+Calmette-Gu%C3%A9rin+versus+maintenance+mitomycin+C+instillation+therapy+in+frequently+recurrent+TaT1+tumours+without+carcinoma+in+situ%3A+a+subgroup+analysis+of+the+prospective%2C+randomised+FinnBladder+I+study+with+a+20-year+follow-up&amp;rft.volume=56&amp;rft.issue=2&amp;rft.pages=260-5&amp;rft.date=2009-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2009.04.009&amp;rft_id=info%3Apmid%2F19395154&amp;rft.aulast=J%C3%A4rvinen&amp;rft.aufirst=R&amp;rft.au=Kaasinen%2C+E&amp;rft.au=Sankila%2C+A&amp;rft.au=Rintala%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19442565-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19442565_8-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Davidson HC, Leibowitz MS, Lopez-Albaitero A, Ferris RL (September 2009). "Immunotherapy for head and neck cancer". <i>Oral Oncol</i>. <b>45</b> (9): 747–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1016%2Fj.oraloncology.2009.02.009">10.1016/j.oraloncology.2009.02.009</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19442565">19442565</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oral+Oncol.&amp;rft.atitle=Immunotherapy+for+head+and+neck+cancer&amp;rft.volume=45&amp;rft.issue=9&amp;rft.pages=747-51&amp;rft.date=2009-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.oraloncology.2009.02.009&amp;rft_id=info%3Apmid%2F19442565&amp;rft.aulast=Davidson&amp;rft.aufirst=HC&amp;rft.au=Leibowitz%2C+MS&amp;rft.au=Lopez-Albaitero%2C+A&amp;rft.au=Ferris%2C+RL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19273388-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19273388_9-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Dani T, Knobler R (2009). "Extracorporeal photoimmunotherapy-photopheresis". <i>Front. Biosci</i>. <b>14</b> (14): 4769–77. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.2741%2F3566">10.2741/3566</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19273388">19273388</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Front.+Biosci.&amp;rft.atitle=Extracorporeal+photoimmunotherapy-photopheresis&amp;rft.volume=14&amp;rft.issue=14&amp;rft.pages=4769-77&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.2741%2F3566&amp;rft_id=info%3Apmid%2F19273388&amp;rft.aulast=Dani&amp;rft.aufirst=T&amp;rft.au=Knobler%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19464602-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19464602_10-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Eggermont AM, Schadendorf D (June 2009). "Melanoma and immunotherapy". <i>Hematol. Oncol. Clin. North Am</i>. <b>23</b> (3): 547–64, ix–x. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1016%2Fj.hoc.2009.03.009">10.1016/j.hoc.2009.03.009</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19464602">19464602</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hematol.+Oncol.+Clin.+North+Am.&amp;rft.atitle=Melanoma+and+immunotherapy&amp;rft.volume=23&amp;rft.issue=3&amp;rft.pages=547-64%2C+ix-x&amp;rft.date=2009-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.hoc.2009.03.009&amp;rft_id=info%3Apmid%2F19464602&amp;rft.aulast=Eggermont&amp;rft.aufirst=AM&amp;rft.au=Schadendorf%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19473507-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19473507_11-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Chuang CM, Monie A, Wu A, Hung CF (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2705346">"Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic anti tumor effects"</a>. <i>J. Biomed. Sci</i>. <b>16</b> (1): 49. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1186%2F1423-0127-16-49">10.1186/1423-0127-16-49</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2705346">2705346</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19473507">19473507</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biomed.+Sci.&amp;rft.atitle=Combination+of+apigenin+treatment+with+therapeutic+HPV+DNA+vaccination+generates+enhanced+therapeutic+anti+tumor+effects&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=49&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2705346&amp;rft_id=info%3Apmid%2F19473507&amp;rft_id=info%3Adoi%2F10.1186%2F1423-0127-16-49&amp;rft.aulast=Chuang&amp;rft.aufirst=CM&amp;rft.au=Monie%2C+A&amp;rft.au=Wu%2C+A&amp;rft.au=Hung%2C+CF&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2705346&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19353471-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19353471_12-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Pawlita M, Gissmann L (April 2009). "[Recurrent respiratory papillomatosis: indication for HPV vaccination?]". <i>Dtsch. Med. Wochenschr.</i> (in German). 134 Suppl 2: S100–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1055%2Fs-0029-1220219">10.1055/s-0029-1220219</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19353471">19353471</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Dtsch.+Med.+Wochenschr.&amp;rft.atitle=%5BRecurrent+respiratory+papillomatosis%3A+indication+for+HPV+vaccination%3F%5D&amp;rft.volume=134+Suppl+2&amp;rft.pages=S100-2&amp;rft.date=2009-04&amp;rft_id=info%3Adoi%2F10.1055%2Fs-0029-1220219&amp;rft_id=info%3Apmid%2F19353471&amp;rft.aulast=Pawlita&amp;rft.aufirst=M&amp;rft.au=Gissmann%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19471115-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19471115_13-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kang N, Zhou J, Zhang T, Wang L, Lu F, Cui Y, Cui L, He W (August 2009). "Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood". <i>Cancer Biol. Ther</i>. <b>8</b> (16): 1540–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.4161%2Fcbt.8.16.8950">10.4161/cbt.8.16.8950</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19471115">19471115</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Biol.+Ther.&amp;rft.atitle=Adoptive+immunotherapy+of+lung+cancer+with+immobilized+anti-TCRgammadelta+antibody-expanded+human+gammadelta+T-cells+in+peripheral+blood&amp;rft.volume=8&amp;rft.issue=16&amp;rft.pages=1540-9&amp;rft.date=2009-08&amp;rft_id=info%3Adoi%2F10.4161%2Fcbt.8.16.8950&amp;rft_id=info%3Apmid%2F19471115&amp;rft.aulast=Kang&amp;rft.aufirst=N&amp;rft.au=Zhou%2C+J&amp;rft.au=Zhang%2C+T&amp;rft.au=Wang%2C+L&amp;rft.au=Lu%2C+F&amp;rft.au=Cui%2C+Y&amp;rft.au=Cui%2C+L&amp;rft.au=He%2C+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid21606971-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21606971_14-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Di Lorenzo G, Buonerba C, Kantoff PW (September 2011). "Immunotherapy for the treatment of prostate cancer". <i>Nature Reviews Clinical Oncology</i>. <b>8</b> (9): 551–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1038%2Fnrclinonc.2011.72">10.1038/nrclinonc.2011.72</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21606971">21606971</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Clinical+Oncology&amp;rft.atitle=Immunotherapy+for+the+treatment+of+prostate+cancer&amp;rft.volume=8&amp;rft.issue=9&amp;rft.pages=551-61&amp;rft.date=2011-09&amp;rft_id=info%3Adoi%2F10.1038%2Fnrclinonc.2011.72&amp;rft_id=info%3Apmid%2F21606971&amp;rft.aulast=Di+Lorenzo&amp;rft.aufirst=G&amp;rft.au=Buonerba%2C+C&amp;rft.au=Kantoff%2C+PW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Rosenberg-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rosenberg_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rosenberg_15-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rosenberg_15-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (April 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2553205">"Adoptive cell transfer: A clinical path to effective cancer immunotherapy"</a>. <i>Nature Reviews Cancer</i>. <b>8</b> (4): 299–308. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1038%2Fnrc2355">10.1038/nrc2355</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2553205">2553205</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18354418">18354418</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.atitle=Adoptive+cell+transfer%3A+A+clinical+path+to+effective+cancer+immunotherapy&amp;rft.volume=8&amp;rft.issue=4&amp;rft.pages=299-308&amp;rft.date=2008-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2553205&amp;rft_id=info%3Apmid%2F18354418&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc2355&amp;rft.aulast=Rosenberg&amp;rft.aufirst=SA&amp;rft.au=Restifo%2C+NP&amp;rft.au=Yang%2C+JC&amp;rft.au=Morgan%2C+RA&amp;rft.au=Dudley%2C+ME&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2553205&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Morgan-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-Morgan_16-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA (October 2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2267026">"Cancer regression in patients after transfer of genetically engineered lymphocytes"</a>. <i>Science</i>. <b>314</b> (5796): 126–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1126%2Fscience.1129003">10.1126/science.1129003</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2267026">2267026</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16946036">16946036</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Cancer+regression+in+patients+after+transfer+of+genetically+engineered+lymphocytes&amp;rft.volume=314&amp;rft.issue=5796&amp;rft.pages=126-9&amp;rft.date=2006-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2267026&amp;rft_id=info%3Apmid%2F16946036&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1129003&amp;rft.aulast=Morgan&amp;rft.aufirst=RA&amp;rft.au=Dudley%2C+ME&amp;rft.au=Wunderlich%2C+JR&amp;rft.au=Hughes%2C+MS&amp;rft.au=Yang%2C+JC&amp;rft.au=Sherry%2C+RM&amp;rft.au=Royal%2C+RE&amp;rft.au=Topalian%2C+SL&amp;rft.au=Kammula%2C+US&amp;rft.au=Restifo%2C+NP&amp;rft.au=Zheng%2C+Z&amp;rft.au=Nahvi%2C+A&amp;rft.au=de+Vries%2C+CR&amp;rft.au=Rogers-Freezer%2C+LJ&amp;rft.au=Mavroukakis%2C+SA&amp;rft.au=Rosenberg%2C+SA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2267026&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Hunder-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hunder_17-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hunder NN, Wallen H, Cao J, Hendricks DW, Reilly JZ, Rodmyre R, Jungbluth A, Gnjatic S, Thompson JA, Yee C (June 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3277288">"Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1"</a>. <i>N. Engl. J. Med</i>. <b>358</b> (25): 2698–703. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1056%2FNEJMoa0800251">10.1056/NEJMoa0800251</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3277288">3277288</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18565862">18565862</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.atitle=Treatment+of+metastatic+melanoma+with+autologous+CD4%2B+T+cells+against+NY-ESO-1&amp;rft.volume=358&amp;rft.issue=25&amp;rft.pages=2698-703&amp;rft.date=2008-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3277288&amp;rft_id=info%3Apmid%2F18565862&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0800251&amp;rft.aulast=Hunder&amp;rft.aufirst=NN&amp;rft.au=Wallen%2C+H&amp;rft.au=Cao%2C+J&amp;rft.au=Hendricks%2C+DW&amp;rft.au=Reilly%2C+JZ&amp;rft.au=Rodmyre%2C+R&amp;rft.au=Jungbluth%2C+A&amp;rft.au=Gnjatic%2C+S&amp;rft.au=Thompson%2C+JA&amp;rft.au=Yee%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3277288&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-urlCancer_Research_Institute_-_2008_Symposium_Program_&amp;_Speakers-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlCancer_Research_Institute_-_2008_Symposium_Program_&amp;_Speakers_18-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20081015045915/http://www.cancerresearch.org/events/symposium/cancer-immunology-immunotherapy-2008/program-speakers.html">"2008 Symposium Program &amp; Speakers"</a>. Cancer Research Institute. Archived from <a rel="nofollow" class="external text" href="http://www.cancerresearch.org/events/symposium/cancer-immunology-immunotherapy-2008/program-speakers.html">the original</a> on 2008-10-15.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=2008+Symposium+Program+%26+Speakers&amp;rft.pub=Cancer+Research+Institute&amp;rft_id=http%3A%2F%2Fwww.cancerresearch.org%2Fevents%2Fsymposium%2Fcancer-immunology-immunotherapy-2008%2Fprogram-speakers.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite class="citation web">Highfield R (18 June 2008). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20080912063314/http://www.telegraph.co.uk/earth/main.jhtml?xml=/earth/2008/06/18/scicanc118.xml">"Cancer patient recovers after injection of immune cells"</a>. <i>The Telegraph</i>. Archived from <a rel="nofollow" class="external text" href="https://www.telegraph.co.uk/earth/main.jhtml?xml=/earth/2008/06/18/scicanc118.xml">the original</a> on 12 September 2008.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Telegraph&amp;rft.atitle=Cancer+patient+recovers+after+injection+of+immune+cells&amp;rft.date=2008-06-18&amp;rft.aulast=Highfield&amp;rft.aufirst=Roger&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Fearth%2Fmain.jhtml%3Fxml%3D%2Fearth%2F2008%2F06%2F18%2Fscicanc118.xml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Antony-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-Antony_20-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, Rosenberg SA, Restifo NP (March 2005). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1403291">"CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells"</a>. <i>Journal of Immunology</i>. <b>174</b> (5): 2591–601. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.4049%2Fjimmunol.174.5.2591">10.4049/jimmunol.174.5.2591</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1403291">1403291</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15728465">15728465</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Immunology&amp;rft.atitle=CD8%2B+T+cell+immunity+against+a+tumor%2Fself-antigen+is+augmented+by+CD4%2B+T+helper+cells+and+hindered+by+naturally+occurring+T+regulatory+cells&amp;rft.volume=174&amp;rft.issue=5&amp;rft.pages=2591-601&amp;rft.date=2005-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1403291&amp;rft_id=info%3Apmid%2F15728465&amp;rft_id=info%3Adoi%2F10.4049%2Fjimmunol.174.5.2591&amp;rft.aulast=Antony&amp;rft.aufirst=PA&amp;rft.au=Piccirillo%2C+CA&amp;rft.au=Akpinarli%2C+A&amp;rft.au=Finkelstein%2C+SE&amp;rft.au=Speiss%2C+PJ&amp;rft.au=Surman%2C+DR&amp;rft.au=Palmer%2C+DC&amp;rft.au=Chan%2C+CC&amp;rft.au=Klebanoff%2C+CA&amp;rft.au=Overwijk%2C+WW&amp;rft.au=Rosenberg%2C+SA&amp;rft.au=Restifo%2C+NP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1403291&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Gattinoni-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gattinoni_21-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, Hwang LN, Yu Z, Wrzesinski C, Heimann DM, Surh CD, Rosenberg SA, Restifo NP (October 2005). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1397916">"Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells"</a>. <i>J. Exp. Med</i>. <b>202</b> (7): 907–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1084%2Fjem.20050732">10.1084/jem.20050732</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1397916">1397916</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16203864">16203864</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Exp.+Med.&amp;rft.atitle=Removal+of+homeostatic+cytokine+sinks+by+lymphodepletion+enhances+the+efficacy+of+adoptively+transferred+tumor-specific+CD8%2B+T+cells&amp;rft.volume=202&amp;rft.issue=7&amp;rft.pages=907-12&amp;rft.date=2005-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1397916&amp;rft_id=info%3Apmid%2F16203864&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.20050732&amp;rft.aulast=Gattinoni&amp;rft.aufirst=L&amp;rft.au=Finkelstein%2C+SE&amp;rft.au=Klebanoff%2C+CA&amp;rft.au=Antony%2C+PA&amp;rft.au=Palmer%2C+DC&amp;rft.au=Spiess%2C+PJ&amp;rft.au=Hwang%2C+LN&amp;rft.au=Yu%2C+Z&amp;rft.au=Wrzesinski%2C+C&amp;rft.au=Heimann%2C+DM&amp;rft.au=Surh%2C+CD&amp;rft.au=Rosenberg%2C+SA&amp;rft.au=Restifo%2C+NP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1397916&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Dummer-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dummer_22-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Dummer W, Niethammer AG, Baccala R, Lawson BR, Wagner N, Reisfeld RA, Theofilopoulos AN (July 2002). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC151053">"T cell homeostatic proliferation elicits effective antitumor autoimmunity"</a>. <i>J. Clin. Invest</i>. <b>110</b> (2): 185–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1172%2FJCI15175">10.1172/JCI15175</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC151053">151053</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12122110">12122110</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.atitle=T+cell+homeostatic+proliferation+elicits+effective+antitumor+autoimmunity&amp;rft.volume=110&amp;rft.issue=2&amp;rft.pages=185-92&amp;rft.date=2002-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC151053&amp;rft_id=info%3Apmid%2F12122110&amp;rft_id=info%3Adoi%2F10.1172%2FJCI15175&amp;rft.aulast=Dummer&amp;rft.aufirst=W&amp;rft.au=Niethammer%2C+AG&amp;rft.au=Baccala%2C+R&amp;rft.au=Lawson%2C+BR&amp;rft.au=Wagner%2C+N&amp;rft.au=Reisfeld%2C+RA&amp;rft.au=Theofilopoulos%2C+AN&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC151053&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Dudley08-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dudley08_23-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, Robbins PF, Huang J, Citrin DE, Leitman SF, Wunderlich J, Restifo NP, Thomasian A, Downey SG, Smith FO, Klapper J, Morton K, Laurencot C, White DE, Rosenberg SA (November 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2652090">"Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens"</a>. <i>J. Clin. Oncol</i>. <b>26</b> (32): 5233–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1200%2FJCO.2008.16.5449">10.1200/JCO.2008.16.5449</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2652090">2652090</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18809613">18809613</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.atitle=Adoptive+cell+therapy+for+patients+with+metastatic+melanoma%3A+evaluation+of+intensive+myeloablative+chemoradiation+preparative+regimens&amp;rft.volume=26&amp;rft.issue=32&amp;rft.pages=5233-9&amp;rft.date=2008-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2652090&amp;rft_id=info%3Apmid%2F18809613&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2008.16.5449&amp;rft.aulast=Dudley&amp;rft.aufirst=ME&amp;rft.au=Yang%2C+JC&amp;rft.au=Sherry%2C+R&amp;rft.au=Hughes%2C+MS&amp;rft.au=Royal%2C+R&amp;rft.au=Kammula%2C+U&amp;rft.au=Robbins%2C+PF&amp;rft.au=Huang%2C+J&amp;rft.au=Citrin%2C+DE&amp;rft.au=Leitman%2C+SF&amp;rft.au=Wunderlich%2C+J&amp;rft.au=Restifo%2C+NP&amp;rft.au=Thomasian%2C+A&amp;rft.au=Downey%2C+SG&amp;rft.au=Smith%2C+FO&amp;rft.au=Klapper%2C+J&amp;rft.au=Morton%2C+K&amp;rft.au=Laurencot%2C+C&amp;rft.au=White%2C+DE&amp;rft.au=Rosenberg%2C+SA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2652090&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Dudley02-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dudley02_24-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA (October 2002). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1764179">"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes"</a>. <i>Science</i>. <b>298</b> (5594): 850–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1126%2Fscience.1076514">10.1126/science.1076514</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1764179">1764179</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12242449">12242449</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Cancer+regression+and+autoimmunity+in+patients+after+clonal+repopulation+with+antitumor+lymphocytes&amp;rft.volume=298&amp;rft.issue=5594&amp;rft.pages=850-4&amp;rft.date=2002-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1764179&amp;rft_id=info%3Apmid%2F12242449&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1076514&amp;rft.aulast=Dudley&amp;rft.aufirst=ME&amp;rft.au=Wunderlich%2C+JR&amp;rft.au=Robbins%2C+PF&amp;rft.au=Yang%2C+JC&amp;rft.au=Hwu%2C+P&amp;rft.au=Schwartzentruber%2C+DJ&amp;rft.au=Topalian%2C+SL&amp;rft.au=Sherry%2C+R&amp;rft.au=Restifo%2C+NP&amp;rft.au=Hubicki%2C+AM&amp;rft.au=Robinson%2C+MR&amp;rft.au=Raffeld%2C+M&amp;rft.au=Duray%2C+P&amp;rft.au=Seipp%2C+CA&amp;rft.au=Rogers-Freezer%2C+L&amp;rft.au=Morton%2C+KE&amp;rft.au=Mavroukakis%2C+SA&amp;rft.au=White%2C+DE&amp;rft.au=Rosenberg%2C+SA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1764179&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid22996367-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22996367_25-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Pilon-Thomas S, Kuhn L, Ellwanger S, Janssen W, Royster E, Marzban S, Kudchadkar R, Zager J, Gibney G, Sondak VK, Weber J, Mulé JJ, Sarnaik AA (October 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4467830">"Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma"</a>. <i>J. Immunother</i>. <b>35</b> (8): 615–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1097%2FCJI.0b013e31826e8f5f">10.1097/CJI.0b013e31826e8f5f</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4467830">4467830</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22996367">22996367</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Immunother.&amp;rft.atitle=Efficacy+of+adoptive+cell+transfer+of+tumor-infiltrating+lymphocytes+after+lymphopenia+induction+for+metastatic+melanoma&amp;rft.volume=35&amp;rft.issue=8&amp;rft.pages=615-20&amp;rft.date=2012-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4467830&amp;rft_id=info%3Apmid%2F22996367&amp;rft_id=info%3Adoi%2F10.1097%2FCJI.0b013e31826e8f5f&amp;rft.aulast=Pilon-Thomas&amp;rft.aufirst=S&amp;rft.au=Kuhn%2C+L&amp;rft.au=Ellwanger%2C+S&amp;rft.au=Janssen%2C+W&amp;rft.au=Royster%2C+E&amp;rft.au=Marzban%2C+S&amp;rft.au=Kudchadkar%2C+R&amp;rft.au=Zager%2C+J&amp;rft.au=Gibney%2C+G&amp;rft.au=Sondak%2C+VK&amp;rft.au=Weber%2C+J&amp;rft.au=Mul%C3%A9%2C+JJ&amp;rft.au=Sarnaik%2C+AA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4467830&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid29688262-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid29688262_26-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Andersen R, Borch TH, Draghi A, Gokuldass A, Rana MA, Pedersen M, Nielsen M, Kongsted P, Kjeldsen JW, Westergaard MC, Radic HD, Chamberlain CA, Holmich LR, Hendel HW, Larsen MS, Met O, Svane IM, Donia M (April 2018). "T cells isolated from patients with checkpoint inhibitor resistant-melanoma are functional and can mediate tumor regression". <i>Ann. Oncol</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1093%2Fannonc%2Fmdy139">10.1093/annonc/mdy139</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/29688262">29688262</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann.+Oncol.&amp;rft.atitle=T+cells+isolated+from+patients+with+checkpoint+inhibitor+resistant-melanoma+are+functional+and+can+mediate+tumor+regression.&amp;rft.date=2018-04&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdy139&amp;rft_id=info%3Apmid%2F29688262&amp;rft.aulast=Andersen&amp;rft.aufirst=R&amp;rft.au=Borch%2C+TH&amp;rft.au=Draghi%2C+A&amp;rft.au=Gokuldass%2C+A&amp;rft.au=Rana%2C+MA&amp;rft.au=Pedersen%2C+M&amp;rft.au=Nielsen%2C+M&amp;rft.au=Kongsted%2C+P&amp;rft.au=Kjeldsen%2C+JW&amp;rft.au=Westergaard%2C+MC&amp;rft.au=Radic%2C+HD&amp;rft.au=Chamberlain%2C+CA&amp;rft.au=Holmich%2C+LR&amp;rft.au=Hendel%2C+HW&amp;rft.au=Larsen%2C+MS&amp;rft.au=Met%2C+O&amp;rft.au=Svane%2C+IM&amp;rft.au=Donia%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Manjunath-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-Manjunath_27-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Manjunath SR, Ramanan G, Dedeepiya VD, Terunuma H, Deng X, Baskar S, Senthilkumar R, Thamaraikannan P, Srinivasan T, Preethy S, Abraham SJ (January 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3364094">"Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case report"</a>. <i>Case Rep. Oncol</i>. <b>5</b> (1): 114–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1159%2F000337319">10.1159/000337319</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3364094">3364094</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22666198">22666198</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Case+Rep.+Oncol.&amp;rft.atitle=Autologous+immune+enhancement+therapy+in+recurrent+ovarian+cancer+with+metastases%3A+a+case+report&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=114-8&amp;rft.date=2012-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3364094&amp;rft_id=info%3Apmid%2F22666198&amp;rft_id=info%3Adoi%2F10.1159%2F000337319&amp;rft.aulast=Manjunath&amp;rft.aufirst=SR&amp;rft.au=Ramanan%2C+G&amp;rft.au=Dedeepiya%2C+VD&amp;rft.au=Terunuma%2C+H&amp;rft.au=Deng%2C+X&amp;rft.au=Baskar%2C+S&amp;rft.au=Senthilkumar%2C+R&amp;rft.au=Thamaraikannan%2C+P&amp;rft.au=Srinivasan%2C+T&amp;rft.au=Preethy%2C+S&amp;rft.au=Abraham%2C+SJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3364094&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Doskali_M-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-Doskali_M_28-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ (December 2004). "Natural killer cells inhibit hepatitis C virus expression". <i>J. Leukoc. Biol</i>. <b>76</b> (6): 1171–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1189%2Fjlb.0604372">10.1189/jlb.0604372</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15339939">15339939</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Leukoc.+Biol.&amp;rft.atitle=Natural+killer+cells+inhibit+hepatitis+C+virus+expression&amp;rft.volume=76&amp;rft.issue=6&amp;rft.pages=1171-9&amp;rft.date=2004-12&amp;rft_id=info%3Adoi%2F10.1189%2Fjlb.0604372&amp;rft_id=info%3Apmid%2F15339939&amp;rft.aulast=Li&amp;rft.aufirst=Y&amp;rft.au=Zhang%2C+T&amp;rft.au=Ho%2C+C&amp;rft.au=Orange%2C+JS&amp;rft.au=Douglas%2C+SD&amp;rft.au=Ho%2C+WZ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Li_Y-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-Li_Y_29-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Doskali M, Tanaka Y, Ohira M, Ishiyama K, Tashiro H, Chayama K, Ohdan H (March 2011). "Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity". <i>J. Immunother</i>. <b>34</b> (2): 129–38. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1097%2FCJI.0b013e3182048c4e">10.1097/CJI.0b013e3182048c4e</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21304407">21304407</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Immunother.&amp;rft.atitle=Possibility+of+adoptive+immunotherapy+with+peripheral+blood-derived+CD3%E2%81%BBCD56%2B+and+CD3%2BCD56%2B+cells+for+inducing+antihepatocellular+carcinoma+and+antihepatitis+C+virus+activity&amp;rft.volume=34&amp;rft.issue=2&amp;rft.pages=129-38&amp;rft.date=2011-03&amp;rft_id=info%3Adoi%2F10.1097%2FCJI.0b013e3182048c4e&amp;rft_id=info%3Apmid%2F21304407&amp;rft.aulast=Doskali&amp;rft.aufirst=M&amp;rft.au=Tanaka%2C+Y&amp;rft.au=Ohira%2C+M&amp;rft.au=Ishiyama%2C+K&amp;rft.au=Tashiro%2C+H&amp;rft.au=Chayama%2C+K&amp;rft.au=Ohdan%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Terunuma_H-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-Terunuma_H_30-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Terunuma H, Deng X, Dewan Z, Fujimoto S, Yamamoto N (2008). "Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections". <i>Int. Rev. Immunol</i>. <b>27</b> (3): 93–110. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1080%2F08830180801911743">10.1080/08830180801911743</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18437601">18437601</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int.+Rev.+Immunol.&amp;rft.atitle=Potential+role+of+NK+cells+in+the+induction+of+immune+responses%3A+implications+for+NK+cell-based+immunotherapy+for+cancers+and+viral+infections&amp;rft.volume=27&amp;rft.issue=3&amp;rft.pages=93-110&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1080%2F08830180801911743&amp;rft_id=info%3Apmid%2F18437601&amp;rft.aulast=Terunuma&amp;rft.aufirst=H&amp;rft.au=Deng%2C+X&amp;rft.au=Dewan%2C+Z&amp;rft.au=Fujimoto%2C+S&amp;rft.au=Yamamoto%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-See_DM-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-See_DM_31-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">See DM, Tilles JG (1996). "alpha-Interferon treatment of patients with chronic fatigue syndrome". <i>Immunol. Invest</i>. <b>25</b> (1–2): 153–64. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.3109%2F08820139609059298">10.3109/08820139609059298</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8675231">8675231</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Immunol.+Invest.&amp;rft.atitle=alpha-Interferon+treatment+of+patients+with+chronic+fatigue+syndrome&amp;rft.volume=25&amp;rft.issue=1%E2%80%932&amp;rft.pages=153-64&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.3109%2F08820139609059298&amp;rft_id=info%3Apmid%2F8675231&amp;rft.aulast=See&amp;rft.aufirst=DM&amp;rft.au=Tilles%2C+JG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Ojo-Amaize_EA-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ojo-Amaize_EA_32-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Ojo-Amaize EA, Conley EJ, Peter JB (January 1994). "Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome". <i>Clin. Infect. Dis</i>. 18 Suppl 1: S157–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1093%2Fclinids%2F18.Supplement_1.S157">10.1093/clinids/18.Supplement_1.S157</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8148445">8148445</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Infect.+Dis.&amp;rft.atitle=Decreased+natural+killer+cell+activity+is+associated+with+severity+of+chronic+fatigue+immune+dysfunction+syndrome&amp;rft.volume=18+Suppl+1&amp;rft.pages=S157-9&amp;rft.date=1994-01&amp;rft_id=info%3Adoi%2F10.1093%2Fclinids%2F18.Supplement_1.S157&amp;rft_id=info%3Apmid%2F8148445&amp;rft.aulast=Ojo-Amaize&amp;rft.aufirst=EA&amp;rft.au=Conley%2C+EJ&amp;rft.au=Peter%2C+JB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-Kida_K-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kida_K_33-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kida K, Isozumi R, Ito M (December 2000). "Killing of human Herpes virus 6-infected cells by lymphocytes cultured with interleukin-2 or -12". <i>Pediatr. Int</i>. <b>42</b> (6): 631–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1046%2Fj.1442-200x.2000.01315.x">10.1046/j.1442-200x.2000.01315.x</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11192519">11192519</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatr.+Int.&amp;rft.atitle=Killing+of+human+Herpes+virus+6-infected+cells+by+lymphocytes+cultured+with+interleukin-2+or+-12&amp;rft.volume=42&amp;rft.issue=6&amp;rft.pages=631-6&amp;rft.date=2000-12&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1442-200x.2000.01315.x&amp;rft_id=info%3Apmid%2F11192519&amp;rft.aulast=Kida&amp;rft.aufirst=K&amp;rft.au=Isozumi%2C+R&amp;rft.au=Ito%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid12110811-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12110811_34-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Rotrosen D, Matthews JB, Bluestone JA (July 2002). "The immune tolerance network: a new paradigm for developing tolerance-inducing therapies". <i>The Journal of Allergy and Clinical Immunology</i>. <b>110</b> (1): 17–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1067%2Fmai.2002.124258">10.1067/mai.2002.124258</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12110811">12110811</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Allergy+and+Clinical+Immunology&amp;rft.atitle=The+immune+tolerance+network%3A+a+new+paradigm+for+developing+tolerance-inducing+therapies&amp;rft.volume=110&amp;rft.issue=1&amp;rft.pages=17-23&amp;rft.date=2002-07&amp;rft_id=info%3Adoi%2F10.1067%2Fmai.2002.124258&amp;rft_id=info%3Apmid%2F12110811&amp;rft.aulast=Rotrosen&amp;rft.aufirst=D&amp;rft.au=Matthews%2C+JB&amp;rft.au=Bluestone%2C+JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid10441602-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10441602_35-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT (August 1999). "Long-term clinical efficacy of grass-pollen immunotherapy". <i>N. Engl. J. Med</i>. <b>341</b> (7): 468–75. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1056%2FNEJM199908123410702">10.1056/NEJM199908123410702</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10441602">10441602</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.atitle=Long-term+clinical+efficacy+of+grass-pollen+immunotherapy&amp;rft.volume=341&amp;rft.issue=7&amp;rft.pages=468-75&amp;rft.date=1999-08&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199908123410702&amp;rft_id=info%3Apmid%2F10441602&amp;rft.aulast=Durham&amp;rft.aufirst=SR&amp;rft.au=Walker%2C+SM&amp;rft.au=Varga%2C+EM&amp;rft.au=Jacobson%2C+MR&amp;rft.au=O%27Brien%2C+F&amp;rft.au=Noble%2C+W&amp;rft.au=Till%2C+SJ&amp;rft.au=Hamid%2C+QA&amp;rft.au=Nouri-Aria%2C+KT&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://med.stanford.edu/clinicaltrials/trials/search?condition=Food%2520Allergy">"Clinical Trials Search Results - Stanford University School of Medicine"</a>. <i>med.stanford.edu</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2016-04-03</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=med.stanford.edu&amp;rft.atitle=Clinical+Trials+Search+Results+-+Stanford+University+School+of+Medicine&amp;rft_id=http%3A%2F%2Fmed.stanford.edu%2Fclinicaltrials%2Ftrials%2Fsearch%3Fcondition%3DFood%252520Allergy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid17230481-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17230481_37-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Correale J, Farez M (February 2007). "Association between parasite infection and immune responses in multiple sclerosis". <i>Annals of Neurology</i>. <b>61</b> (2): 97–108. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1002%2Fana.21067">10.1002/ana.21067</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17230481">17230481</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Association+between+parasite+infection+and+immune+responses+in+multiple+sclerosis&amp;rft.volume=61&amp;rft.issue=2&amp;rft.pages=97-108&amp;rft.date=2007-02&amp;rft_id=info%3Adoi%2F10.1002%2Fana.21067&amp;rft_id=info%3Apmid%2F17230481&amp;rft.aulast=Correale&amp;rft.aufirst=J&amp;rft.au=Farez%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid16344586-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16344586_38-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Croese J, O'neil J, Masson J, Cooke S, Melrose W, Pritchard D, Speare R (January 2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1856386">"A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors"</a>. <i>Gut</i>. <b>55</b> (1): 136–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1136%2Fgut.2005.079129">10.1136/gut.2005.079129</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1856386">1856386</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16344586">16344586</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gut&amp;rft.atitle=A+proof+of+concept+study+establishing+Necator+americanus+in+Crohn%27s+patients+and+reservoir+donors&amp;rft.volume=55&amp;rft.issue=1&amp;rft.pages=136-7&amp;rft.date=2006-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1856386&amp;rft_id=info%3Apmid%2F16344586&amp;rft_id=info%3Adoi%2F10.1136%2Fgut.2005.079129&amp;rft.aulast=Croese&amp;rft.aufirst=J&amp;rft.au=O%27neil%2C+J&amp;rft.au=Masson%2C+J&amp;rft.au=Cooke%2C+S&amp;rft.au=Melrose%2C+W&amp;rft.au=Pritchard%2C+D&amp;rft.au=Speare%2C+R&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1856386&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19050918-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19050918_39-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Reddy A, Fried B (January 2009). "An update on the use of helminths to treat Crohn's and other autoimmunune diseases". <i>Parasitol. Res</i>. <b>104</b> (2): 217–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1007%2Fs00436-008-1297-5">10.1007/s00436-008-1297-5</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19050918">19050918</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parasitol.+Res.&amp;rft.atitle=An+update+on+the+use+of+helminths+to+treat+Crohn%27s+and+other+autoimmunune+diseases&amp;rft.volume=104&amp;rft.issue=2&amp;rft.pages=217-21&amp;rft.date=2009-01&amp;rft_id=info%3Adoi%2F10.1007%2Fs00436-008-1297-5&amp;rft_id=info%3Apmid%2F19050918&amp;rft.aulast=Reddy&amp;rft.aufirst=A&amp;rft.au=Fried%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid18619749-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18619749_40-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Laclotte C, Oussalah A, Rey P, Bensenane M, Pluvinage N, Chevaux JB, Trouilloud I, Serre AA, Boucekkine T, Bigard MA, Peyrin-Biroulet L (December 2008). "[Helminths and inflammatory bowel diseases]". <i>Gastroenterol. Clin. Biol.</i> (in French). <b>32</b> (12): 1064–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1016%2Fj.gcb.2008.04.030">10.1016/j.gcb.2008.04.030</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18619749">18619749</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gastroenterol.+Clin.+Biol.&amp;rft.atitle=%5BHelminths+and+inflammatory+bowel+diseases%5D&amp;rft.volume=32&amp;rft.issue=12&amp;rft.pages=1064-74&amp;rft.date=2008-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.gcb.2008.04.030&amp;rft_id=info%3Apmid%2F18619749&amp;rft.aulast=Laclotte&amp;rft.aufirst=C&amp;rft.au=Oussalah%2C+A&amp;rft.au=Rey%2C+P&amp;rft.au=Bensenane%2C+M&amp;rft.au=Pluvinage%2C+N&amp;rft.au=Chevaux%2C+JB&amp;rft.au=Trouilloud%2C+I&amp;rft.au=Serre%2C+AA&amp;rft.au=Boucekkine%2C+T&amp;rft.au=Bigard%2C+MA&amp;rft.au=Peyrin-Biroulet%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid16965287-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16965287_41-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Zaccone P, Fehervari Z, Phillips JM, Dunne DW, Cooke A (October 2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1618732">"Parasitic worms and inflammatory diseases"</a>. <i>Parasite Immunol</i>. <b>28</b> (10): 515–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1111%2Fj.1365-3024.2006.00879.x">10.1111/j.1365-3024.2006.00879.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1618732">1618732</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16965287">16965287</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parasite+Immunol.&amp;rft.atitle=Parasitic+worms+and+inflammatory+diseases&amp;rft.volume=28&amp;rft.issue=10&amp;rft.pages=515-23&amp;rft.date=2006-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1618732&amp;rft_id=info%3Apmid%2F16965287&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-3024.2006.00879.x&amp;rft.aulast=Zaccone&amp;rft.aufirst=P&amp;rft.au=Fehervari%2C+Z&amp;rft.au=Phillips%2C+JM&amp;rft.au=Dunne%2C+DW&amp;rft.au=Cooke%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1618732&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid15603764-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15603764_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15603764_42-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Brooker S, Bethony J, Hotez PJ (2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2268732">"Human Hookworm Infection in the 21st Century"</a>. <i>Advances in Parasitology</i>. <b>58</b>: 197–288. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1016%2FS0065-308X%2804%2958004-1">10.1016/S0065-308X(04)58004-1</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780120317585" title="Special:BookSources/9780120317585">9780120317585</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2268732">2268732</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15603764">15603764</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Parasitology&amp;rft.atitle=Human+Hookworm+Infection+in+the+21st+Century&amp;rft.volume=58&amp;rft.pages=197-288&amp;rft.date=2004&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2268732&amp;rft_id=info%3Apmid%2F15603764&amp;rft_id=info%3Adoi%2F10.1016%2FS0065-308X%2804%2958004-1&amp;rft.isbn=9780120317585&amp;rft.aulast=Brooker&amp;rft.aufirst=S&amp;rft.au=Bethony%2C+J&amp;rft.au=Hotez%2C+PJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2268732&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19308259-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19308259_43-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Fujiwara RT, Cançado GG, Freitas PA, Santiago HC, Massara CL, Dos Santos Carvalho O, Corrêa-Oliveira R, Geiger SM, Bethony J (2009).  Yazdanbakhsh M, ed. <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2654967">"Necator americanus infection: a possible cause of altered dendritic cell differentiation and eosinophil profile in chronically infected individuals"</a>. <i>PLoS Negl. Trop. Dis</i>. <b>3</b> (3): e399. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1371%2Fjournal.pntd.0000399">10.1371/journal.pntd.0000399</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2654967">2654967</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19308259">19308259</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLoS+Negl.+Trop.+Dis.&amp;rft.atitle=Necator+americanus+infection%3A+a+possible+cause+of+altered+dendritic+cell+differentiation+and+eosinophil+profile+in+chronically+infected+individuals&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=e399&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2654967&amp;rft_id=info%3Apmid%2F19308259&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pntd.0000399&amp;rft.aulast=Fujiwara&amp;rft.aufirst=RT&amp;rft.au=Can%C3%A7ado%2C+GG&amp;rft.au=Freitas%2C+PA&amp;rft.au=Santiago%2C+HC&amp;rft.au=Massara%2C+CL&amp;rft.au=Dos+Santos+Carvalho%2C+O&amp;rft.au=Corr%C3%AAa-Oliveira%2C+R&amp;rft.au=Geiger%2C+SM&amp;rft.au=Bethony%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2654967&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19120496-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19120496_44-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Carvalho L, Sun J, Kane C, Marshall F, Krawczyk C, Pearce EJ (January 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2632707">"Review series on helminths, immune modulation and the hygiene hypothesis: mechanisms underlying helminth modulation of dendritic cell function"</a>. <i>Immunology</i>. <b>126</b> (1): 28–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1111%2Fj.1365-2567.2008.03008.x">10.1111/j.1365-2567.2008.03008.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2632707">2632707</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19120496">19120496</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Immunology&amp;rft.atitle=Review+series+on+helminths%2C+immune+modulation+and+the+hygiene+hypothesis%3A+mechanisms+underlying+helminth+modulation+of+dendritic+cell+function&amp;rft.volume=126&amp;rft.issue=1&amp;rft.pages=28-34&amp;rft.date=2009-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2632707&amp;rft_id=info%3Apmid%2F19120496&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2567.2008.03008.x&amp;rft.aulast=Carvalho&amp;rft.aufirst=L&amp;rft.au=Sun%2C+J&amp;rft.au=Kane%2C+C&amp;rft.au=Marshall%2C+F&amp;rft.au=Krawczyk%2C+C&amp;rft.au=Pearce%2C+EJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2632707&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
<li id="cite_note-pmid19468064-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19468064_45-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Fumagalli M, Pozzoli U, Cagliani R, Comi GP, Riva S, Clerici M, Bresolin N, Sironi M (June 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2715056">"Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions"</a>. <i>J. Exp. Med</i>. <b>206</b> (6): 1395–408. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//doi.org/10.1084%2Fjem.20082779">10.1084/jem.20082779</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2715056">2715056</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19468064">19468064</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Exp.+Med.&amp;rft.atitle=Parasites+represent+a+major+selective+force+for+interleukin+genes+and+shape+the+genetic+predisposition+to+autoimmune+conditions&amp;rft.volume=206&amp;rft.issue=6&amp;rft.pages=1395-408&amp;rft.date=2009-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2715056&amp;rft_id=info%3Apmid%2F19468064&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.20082779&amp;rft.aulast=Fumagalli&amp;rft.aufirst=M&amp;rft.au=Pozzoli%2C+U&amp;rft.au=Cagliani%2C+R&amp;rft.au=Comi%2C+GP&amp;rft.au=Riva%2C+S&amp;rft.au=Clerici%2C+M&amp;rft.au=Bresolin%2C+N&amp;rft.au=Sironi%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2715056&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></span>
</li>
</ol></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Immunotherapy&amp;action=edit&amp;section=14" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><cite class="citation news">Langreth, Robert (12 February 2009). <a rel="nofollow" class="external text" href="https://www.forbes.com/forbes/2009/0302/074_cancer_miracles.html">"Cancer Miracles"</a>. <i>Forbes</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=Cancer+Miracles&amp;rft.date=2009-02-12&amp;rft.aulast=Langreth&amp;rft.aufirst=Robert&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fforbes%2F2009%2F0302%2F074_cancer_miracles.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AImmunotherapy" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r861714446"/></li>
<li><a rel="nofollow" class="external text" href="http://www.isbtc.org/about/">International Society for Biological Therapy of Cancer</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cancerresearch.org/programs/meetings/symposium.html/">Cancer Research Institute Annual International Cancer Immunotherapy Symposia Series</a></li></ul>
<div class="noprint metadata navbox" role="navigation" aria-label="Portals" style="font-weight:bold;padding:0.4em 2em"><ul style="margin:0.1em 0 0"><li style="display:inline"><span style="display:inline-block;white-space:nowrap"><span style="margin:0 0.5em"><a href="/wiki/File:Issoria_lathonia.jpg" class="image"><img alt="Issoria lathonia.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/24px-Issoria_lathonia.jpg" decoding="async" width="24" height="17" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/36px-Issoria_lathonia.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/48px-Issoria_lathonia.jpg 2x" data-file-width="629" data-file-height="445" /></a></span><a href="/wiki/Portal:Biology" title="Portal:Biology">Biology portal</a></span></li><li style="display:inline"><span style="display:inline-block;white-space:nowrap"><span style="margin:0 0.5em"><a href="/wiki/File:WHO_Rod.svg" class="image"><img alt="WHO Rod.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/9px-WHO_Rod.svg.png" decoding="async" width="9" height="21" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/13px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/18px-WHO_Rod.svg.png 2x" data-file-width="107" data-file-height="250" /></a></span><a href="/wiki/Portal:Medicine" title="Portal:Medicine">Medicine portal</a></span></li></ul></div>
<div role="navigation" class="navbox" aria-labelledby="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q1427096&amp;#124;Edit_this_at_Wikidata" style="padding:3px"><table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th id="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q1427096&amp;#124;Edit_this_at_Wikidata" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a> <a href="https://www.wikidata.org/wiki/Q1427096" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x" data-file-width="600" data-file-height="600" /></a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="nowrap"><a href="/wiki/National_Diet_Library" title="National Diet Library">NDL</a>: <span class="uid"><a rel="nofollow" class="external text" href="https://id.ndl.go.jp/auth/ndlna/00567589">00567589</a></span></span></li></ul>
</div></td></tr></tbody></table></div>

<!-- 
NewPP limit report
Parsed by mw1256
Cached time: 20190116031605
Cache expiry: 1900800
Dynamic content: false
CPU time usage: 0.832 seconds
Real time usage: 0.962 seconds
Preprocessor visited node count: 2787/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 131516/2097152 bytes
Template argument size: 1160/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 9/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 147800/5000000 bytes
Number of Wikibase entities loaded: 3/400
Lua time usage: 0.548/10.000 seconds
Lua memory usage: 6.18 MB/50 MB
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  837.328      1 -total
 67.07%  561.556      1 Template:Reflist
 50.03%  418.926     41 Template:Cite_journal
  9.47%   79.310      4 Template:Cite_web
  6.32%   52.917      1 Template:Infobox_medical_intervention
  5.78%   48.408      1 Template:Infobox
  4.99%   41.744      1 Template:Medical_citations_needed
  4.70%   39.393      2 Template:Ambox
  4.46%   37.303      2 Template:Citation_needed
  3.89%   32.588      2 Template:Fix
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:226533-0!canonical and timestamp 20190116031604 and revision id 875634703
 -->
</div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Immunotherapy&amp;oldid=875634703">https://en.wikipedia.org/w/index.php?title=Immunotherapy&amp;oldid=875634703</a>"					</div>
				<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Immunotherapy" title="Category:Immunotherapy">Immunotherapy</a></li><li><a href="/wiki/Category:Cancer_treatments" title="Category:Cancer treatments">Cancer treatments</a></li><li><a href="/wiki/Category:Virotherapy" title="Category:Virotherapy">Virotherapy</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_German-language_sources_(de)" title="Category:CS1 German-language sources (de)">CS1 German-language sources (de)</a></li><li><a href="/wiki/Category:CS1_French-language_sources_(fr)" title="Category:CS1 French-language sources (fr)">CS1 French-language sources (fr)</a></li><li><a href="/wiki/Category:Articles_needing_additional_medical_references_from_April_2018" title="Category:Articles needing additional medical references from April 2018">Articles needing additional medical references from April 2018</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_requiring_reliable_medical_sources" title="Category:Articles requiring reliable medical sources">Articles requiring reliable medical sources</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_April_2018" title="Category:Articles lacking reliable references from April 2018">Articles lacking reliable references from April 2018</a></li><li><a href="/wiki/Category:All_articles_lacking_reliable_references" title="Category:All articles lacking reliable references">All articles lacking reliable references</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_March_2013" title="Category:Articles with unsourced statements from March 2013">Articles with unsourced statements from March 2013</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_April_2016" title="Category:Articles with unsourced statements from April 2016">Articles with unsourced statements from April 2016</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_NDL_identifiers" title="Category:Wikipedia articles with NDL identifiers">Wikipedia articles with NDL identifiers</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>
			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n">Talk</a></li><li id="pt-anoncontribs"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Immunotherapy" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Immunotherapy" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
							<li id="ca-nstab-main" class="selected"><span><a href="/wiki/Immunotherapy" title="View the content page [c]" accesskey="c">Article</a></span></li><li id="ca-talk"><span><a href="/wiki/Talk:Immunotherapy" rel="discussion" title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>						</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<input type="checkbox" class="vectorMenuCheckbox" aria-labelledby="p-variants-label" />
						<h3 id="p-variants-label">
							<span>Variants</span>
						</h3>
						<ul class="menu">
													</ul>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
							<li id="ca-view" class="collapsible selected"><span><a href="/wiki/Immunotherapy">Read</a></span></li><li id="ca-edit" class="collapsible"><span><a href="/w/index.php?title=Immunotherapy&amp;action=edit" title="Edit this page [e]" accesskey="e">Edit</a></span></li><li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Immunotherapy&amp;action=history" title="Past revisions of this page [h]" accesskey="h">View history</a></span></li>						</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<input type="checkbox" class="vectorMenuCheckbox" aria-labelledby="p-cactions-label" />
						<h3 id="p-cactions-label"><span>More</span></h3>
						<ul class="menu">
													</ul>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>
						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
								<input type="search" name="search" placeholder="Search Wikipedia" title="Search Wikipedia [f]" accesskey="f" id="searchInput"/><input type="hidden" value="Special:Search" name="title"/><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton"/><input type="submit" name="go" value="Go" title="Go to a page with this exact name if it exists" id="searchButton" class="searchButton"/>							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id="p-navigation" aria-labelledby="p-navigation-label">
			<h3 id="p-navigation-label">Navigation</h3>
			<div class="body">
								<ul>
					<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikipedia store">Wikipedia store</a></li>				</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id="p-interaction" aria-labelledby="p-interaction-label">
			<h3 id="p-interaction-label">Interaction</h3>
			<div class="body">
								<ul>
					<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact page</a></li>				</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id="p-tb" aria-labelledby="p-tb-label">
			<h3 id="p-tb-label">Tools</h3>
			<div class="body">
								<ul>
					<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Immunotherapy" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Immunotherapy" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Immunotherapy&amp;oldid=875634703" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Immunotherapy&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q1427096" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Immunotherapy&amp;id=875634703" title="Information on how to cite this page">Cite this page</a></li>				</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id="p-coll-print_export" aria-labelledby="p-coll-print_export-label">
			<h3 id="p-coll-print_export-label">Print/export</h3>
			<div class="body">
								<ul>
					<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Immunotherapy">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:ElectronPdf&amp;page=Immunotherapy&amp;action=show-download-screen">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Immunotherapy&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id="p-wikibase-otherprojects" aria-labelledby="p-wikibase-otherprojects-label">
			<h3 id="p-wikibase-otherprojects-label">In other projects</h3>
			<div class="body">
								<ul>
					<li class="wb-otherproject-link wb-otherproject-commons"><a href="https://commons.wikimedia.org/wiki/Category:Immunotherapy" hreflang="en">Wikimedia Commons</a></li>				</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id="p-lang" aria-labelledby="p-lang-label">
			<h3 id="p-lang-label">Languages</h3>
			<div class="body">
								<ul>
					<li class="interlanguage-link interwiki-ar"><a href="https://ar.wikipedia.org/wiki/%D8%B9%D9%84%D8%A7%D8%AC_%D9%85%D9%86%D8%A7%D8%B9%D9%8A" title="علاج مناعي – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target">العربية</a></li><li class="interlanguage-link interwiki-bg"><a href="https://bg.wikipedia.org/wiki/%D0%98%D0%BC%D1%83%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8F" title="Имунотерапия – Bulgarian" lang="bg" hreflang="bg" class="interlanguage-link-target">Български</a></li><li class="interlanguage-link interwiki-ca"><a href="https://ca.wikipedia.org/wiki/Immunoter%C3%A0pia" title="Immunoteràpia – Catalan" lang="ca" hreflang="ca" class="interlanguage-link-target">Català</a></li><li class="interlanguage-link interwiki-cs"><a href="https://cs.wikipedia.org/wiki/Imunoterapie" title="Imunoterapie – Czech" lang="cs" hreflang="cs" class="interlanguage-link-target">Čeština</a></li><li class="interlanguage-link interwiki-de"><a href="https://de.wikipedia.org/wiki/Immuntherapie" title="Immuntherapie – German" lang="de" hreflang="de" class="interlanguage-link-target">Deutsch</a></li><li class="interlanguage-link interwiki-et"><a href="https://et.wikipedia.org/wiki/Immunoteraapia" title="Immunoteraapia – Estonian" lang="et" hreflang="et" class="interlanguage-link-target">Eesti</a></li><li class="interlanguage-link interwiki-el"><a href="https://el.wikipedia.org/wiki/%CE%91%CE%BD%CE%BF%CF%83%CE%BF%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CE%AF%CE%B1" title="Ανοσοθεραπεία – Greek" lang="el" hreflang="el" class="interlanguage-link-target">Ελληνικά</a></li><li class="interlanguage-link interwiki-es"><a href="https://es.wikipedia.org/wiki/Inmunoterapia" title="Inmunoterapia – Spanish" lang="es" hreflang="es" class="interlanguage-link-target">Español</a></li><li class="interlanguage-link interwiki-eu"><a href="https://eu.wikipedia.org/wiki/Immunoterapia" title="Immunoterapia – Basque" lang="eu" hreflang="eu" class="interlanguage-link-target">Euskara</a></li><li class="interlanguage-link interwiki-fa"><a href="https://fa.wikipedia.org/wiki/%D8%A7%DB%8C%D9%85%D9%88%D9%86%D9%88%D8%AA%D8%B1%D8%A7%D9%BE%DB%8C" title="ایمونوتراپی – Persian" lang="fa" hreflang="fa" class="interlanguage-link-target">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="https://fr.wikipedia.org/wiki/Immunoth%C3%A9rapie" title="Immunothérapie – French" lang="fr" hreflang="fr" class="interlanguage-link-target">Français</a></li><li class="interlanguage-link interwiki-gl"><a href="https://gl.wikipedia.org/wiki/Inmunoterapia" title="Inmunoterapia – Galician" lang="gl" hreflang="gl" class="interlanguage-link-target">Galego</a></li><li class="interlanguage-link interwiki-ko"><a href="https://ko.wikipedia.org/wiki/%EB%A9%B4%EC%97%AD%EC%9A%94%EB%B2%95" title="면역요법 – Korean" lang="ko" hreflang="ko" class="interlanguage-link-target">한국어</a></li><li class="interlanguage-link interwiki-id"><a href="https://id.wikipedia.org/wiki/Imunoterapi" title="Imunoterapi – Indonesian" lang="id" hreflang="id" class="interlanguage-link-target">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-he"><a href="https://he.wikipedia.org/wiki/%D7%90%D7%99%D7%9E%D7%95%D7%A0%D7%95%D7%AA%D7%A8%D7%A4%D7%99%D7%94" title="אימונותרפיה – Hebrew" lang="he" hreflang="he" class="interlanguage-link-target">עברית</a></li><li class="interlanguage-link interwiki-kk"><a href="https://kk.wikipedia.org/wiki/%D0%98%D0%BC%D0%BC%D1%83%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8F" title="Иммунотерапия – Kazakh" lang="kk" hreflang="kk" class="interlanguage-link-target">Қазақша</a></li><li class="interlanguage-link interwiki-hu"><a href="https://hu.wikipedia.org/wiki/Immunter%C3%A1pia" title="Immunterápia – Hungarian" lang="hu" hreflang="hu" class="interlanguage-link-target">Magyar</a></li><li class="interlanguage-link interwiki-nl"><a href="https://nl.wikipedia.org/wiki/Immunotherapie" title="Immunotherapie – Dutch" lang="nl" hreflang="nl" class="interlanguage-link-target">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="https://ja.wikipedia.org/wiki/%E5%85%8D%E7%96%AB%E7%99%82%E6%B3%95" title="免疫療法 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="https://pl.wikipedia.org/wiki/Immunoterapia" title="Immunoterapia – Polish" lang="pl" hreflang="pl" class="interlanguage-link-target">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="https://pt.wikipedia.org/wiki/Imunoterapia" title="Imunoterapia – Portuguese" lang="pt" hreflang="pt" class="interlanguage-link-target">Português</a></li><li class="interlanguage-link interwiki-ro"><a href="https://ro.wikipedia.org/wiki/Imunoterapie" title="Imunoterapie – Romanian" lang="ro" hreflang="ro" class="interlanguage-link-target">Română</a></li><li class="interlanguage-link interwiki-ru"><a href="https://ru.wikipedia.org/wiki/%D0%98%D0%BC%D0%BC%D1%83%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8F" title="Иммунотерапия – Russian" lang="ru" hreflang="ru" class="interlanguage-link-target">Русский</a></li><li class="interlanguage-link interwiki-fi"><a href="https://fi.wikipedia.org/wiki/Immunoterapia" title="Immunoterapia – Finnish" lang="fi" hreflang="fi" class="interlanguage-link-target">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="https://sv.wikipedia.org/wiki/Immunterapi" title="Immunterapi – Swedish" lang="sv" hreflang="sv" class="interlanguage-link-target">Svenska</a></li><li class="interlanguage-link interwiki-ta"><a href="https://ta.wikipedia.org/wiki/%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%86%E0%AE%A4%E0%AE%BF%E0%AE%B0%E0%AF%8D%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%BF%E0%AE%AF%E0%AE%9A%E0%AF%8D_%E0%AE%9A%E0%AE%BF%E0%AE%95%E0%AE%BF%E0%AE%9A%E0%AF%8D%E0%AE%9A%E0%AF%88" title="நோயெதிர்ப்பியச் சிகிச்சை – Tamil" lang="ta" hreflang="ta" class="interlanguage-link-target">தமிழ்</a></li><li class="interlanguage-link interwiki-uk"><a href="https://uk.wikipedia.org/wiki/%D0%86%D0%BC%D1%83%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D1%96%D1%8F" title="Імунотерапія – Ukrainian" lang="uk" hreflang="uk" class="interlanguage-link-target">Українська</a></li><li class="interlanguage-link interwiki-ur"><a href="https://ur.wikipedia.org/wiki/%D9%85%D8%B9%D8%A7%D9%84%D8%AC%DB%82_%D9%85%D9%86%D8%A7%D8%B9%DB%8C%DB%81" title="معالجۂ مناعیہ – Urdu" lang="ur" hreflang="ur" class="interlanguage-link-target">اردو</a></li><li class="interlanguage-link interwiki-zh"><a href="https://zh.wikipedia.org/wiki/%E5%85%8D%E7%96%AB%E6%B2%BB%E7%96%97" title="免疫治疗 – Chinese" lang="zh" hreflang="zh" class="interlanguage-link-target">中文</a></li>				</ul>
				<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q1427096#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
				<div id="footer" role="contentinfo">
						<ul id="footer-info">
								<li id="footer-info-lastmod"> This page was last edited on 28 December 2018, at 00:07<span class="anonymous-show">&#160;(UTC)</span>.</li>
								<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
							</ul>
						<ul id="footer-places">
								<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy policy</a></li>
								<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
								<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
								<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
								<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
								<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Cookie_statement">Cookie statement</a></li>
								<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Immunotherapy&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
							</ul>
										<ul id="footer-icons" class="noprint">
										<li id="footer-copyrightico">
						<a href="https://wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>					</li>
										<li id="footer-poweredbyico">
						<a href="//www.mediawiki.org/"><img src="/static/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x" width="88" height="31"/></a>					</li>
									</ul>
						<div style="clear: both;"></div>
		</div>
		
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.832","walltime":"0.962","ppvisitednodes":{"value":2787,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":131516,"limit":2097152},"templateargumentsize":{"value":1160,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":9,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":147800,"limit":5000000},"entityaccesscount":{"value":3,"limit":400},"timingprofile":["100.00%  837.328      1 -total"," 67.07%  561.556      1 Template:Reflist"," 50.03%  418.926     41 Template:Cite_journal","  9.47%   79.310      4 Template:Cite_web","  6.32%   52.917      1 Template:Infobox_medical_intervention","  5.78%   48.408      1 Template:Infobox","  4.99%   41.744      1 Template:Medical_citations_needed","  4.70%   39.393      2 Template:Ambox","  4.46%   37.303      2 Template:Citation_needed","  3.89%   32.588      2 Template:Fix"]},"scribunto":{"limitreport-timeusage":{"value":"0.548","limit":"10.000"},"limitreport-memusage":{"value":6477218,"limit":52428800}},"cachereport":{"origin":"mw1256","timestamp":"20190116031605","ttl":1900800,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Immunotherapy","url":"https:\/\/en.wikipedia.org\/wiki\/Immunotherapy","sameAs":"http:\/\/www.wikidata.org\/entity\/Q1427096","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q1427096","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2003-05-13T18:13:18Z","dateModified":"2018-12-28T00:07:08Z","headline":"therapy to elicit or amplify an immune response"}</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":99,"wgHostname":"mw1325"});});</script>
	</body>
</html>
